AIM ImmunoTech Inc (AIM)
0.43
0.00 (0.00%)
USD |
NYAM |
Apr 24, 16:00
AIM ImmunoTech Free Cash Flow: -21.85M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -21.85M |
| September 30, 2023 | -18.14M |
| June 30, 2023 | -17.27M |
| March 31, 2023 | -17.27M |
| December 31, 2022 | -16.38M |
| September 30, 2022 | -16.04M |
| June 30, 2022 | -14.59M |
| March 31, 2022 | -13.98M |
| December 31, 2021 | -14.60M |
| September 30, 2021 | -11.84M |
| June 30, 2021 | -11.29M |
| March 31, 2021 | -11.01M |
| December 31, 2020 | -10.96M |
| September 30, 2020 | -10.21M |
| June 30, 2020 | -9.782M |
| March 31, 2020 | -11.20M |
| December 31, 2019 | -9.432M |
| September 30, 2019 | -9.479M |
| June 30, 2019 | -9.946M |
| March 31, 2019 | -9.806M |
| December 31, 2018 | -10.77M |
| September 30, 2018 | -9.109M |
| June 30, 2018 | -7.994M |
| March 31, 2018 | -7.559M |
| December 31, 2017 | -8.01M |
| Date | Value |
|---|---|
| September 30, 2017 | -9.351M |
| June 30, 2017 | -10.49M |
| March 31, 2017 | -9.736M |
| December 31, 2016 | -7.834M |
| September 30, 2016 | -9.11M |
| June 30, 2016 | -9.556M |
| March 31, 2016 | -13.20M |
| December 31, 2015 | -16.54M |
| September 30, 2015 | -17.38M |
| June 30, 2015 | -17.78M |
| March 31, 2015 | -16.14M |
| December 31, 2014 | -14.73M |
| September 30, 2014 | -13.97M |
| June 30, 2014 | -14.35M |
| March 31, 2014 | -14.94M |
| December 31, 2013 | -18.04M |
| September 30, 2013 | -20.56M |
| June 30, 2013 | -20.67M |
| March 31, 2013 | -22.03M |
| December 31, 2012 | -19.10M |
| September 30, 2012 | -17.23M |
| June 30, 2012 | -15.61M |
| March 31, 2012 | -13.35M |
| December 31, 2011 | -12.13M |
| September 30, 2011 | -10.18M |
Free Cash Flow Range, Past 5 Years
-21.85M
Minimum
Dec 2023
-9.432M
Maximum
Dec 2019
-13.43M
Average
-11.84M
Median
Sep 2021
Free Cash Flow Benchmarks
| Perspective Therapeutics Inc | -37.98M |
| Protalix BioTherapeutics Inc | -2.467M |
| Electromed Inc | 3.653M |
| Xtant Medical Holdings Inc | -10.97M |
| Armata Pharmaceuticals Inc | -55.57M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -9.758M |
| Cash from Investing (Quarterly) | -0.214M |
| Cash from Financing (Quarterly) | 0.147M |
| Free Cash Flow Per Share (Quarterly) | -0.2036 |
| Free Cash Flow to Equity (Quarterly) | -9.956M |
| Free Cash Flow Yield | -104.6% |